CHIMERIC THERAPEUTICS LIMITED — Director's Dealing 2021

Jan 18, 2021

Appendix 3X Initial Director’s Interest Notice

Rule 3.19A.1

Appendix 3X

Initial Director’s Interest Notice

Information or documents not available now must be given to ASX as soon as available. Information and documents given to ASX become ASX’s property and may be made public.

Introduced 30/9/2001.

Name of Entity: Chimeric Therapeutics Limited (ASX: CHM) ABN: 68 638 835 828

We (the entity) give ASX the following information under listing rule 3.19A.1 and as agent for the director for the purposes of section 205G of the Corporations Act.

Name of Director:	Leslie Chong
Date of Appointment:	28 August 2020

Part 1 - Director’s relevant interests in securities of which the director is the registered holder

In the case of a trust, this includes interests in the trust made available by the responsible entity of the trust

Note: In the case of a company, interests which come within paragraph (i) of the definition of “notifiable interest of a director” should be disclosed in this part.

Number	Class of Securities
2,750,000	Unlisted Options (subject to escrow for 24 months from official quotation)

• See chapter 19 for defined terms.

11/3/2002

Appendix 3X Page 1

Appendix 3X Initial Director’s Interest Notice

Part 2 – Director’s relevant interests in securities of which the director is not the registered holder

In the case of a trust, this includes interests in the trust made available by the responsible entity of the trust

Name of holder & nature of interestNote: Provide details of the circumstances giving rise to therelevant interest.	Number	Class of Securities
Nil	Nil	Nil

Part 3 – Director’s interests in contracts

Note: In the case of a company, interests which come within paragraph (ii) of the definition of “notifiable interest of a director” should be disclosed in this part.

	: In the case of a company, interests which comepart.	: In the case of a company, interests which comepart.	within paragraph (ii) of the definit	within paragraph (ii) of the definit	ion of notifiable interest of a dire	ctor should be disclosed in	ctor should be disclosed in
D
	etail of contract			Employment Co	ntract
Nature of interest	ature of interest			2,750,000 unlistOmnibus Ince	ed options granted frntive Plan (OIP)	om the Company’s
				Th ti	.ll b td i	d ith th
				e opons wterms of the C	e grane n acompany’s Omnibus I	orance w encentive Plan (OIP)
				and will inclu	e the following terms	and conditions:
				Issue price: Nil.
				Exercise Price w	ill be at $0.20 per opt	ion.
				Expiry Date: 18	January 2025
				Vesting conditioi.33%	ns: Vesting annually awill vest upon compl	s follows:etion of the offer
				ii.33%the	will vest 12 monthsoffer.	from completion of
				iii.Thefrom	remaining 34% wilcompletion of the of	l vest 24 monthsfer.
Name of registered holder(if issued securities)				Ms Mi Ok Chong
No. and class of securities towhich interest relates				2,750,000 unlisted options

• See chapter 19 for defined terms.

Appendix 3X Page 2

11/3/2002